51³Ô¹ÏÍø
Tag - lecanemab
Subscribe
Digital
Print
July 24, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
LECANEMAB
51³Ô¹ÏÍø
/
Science & Health
Jul 21, 2026
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
The discovery of a new seed of the amyloid beta protein could lead to early-stage therapy for neurodegenerative disease, according to researchers.
51³Ô¹ÏÍø
/
Science & Health
Apr 8, 2026
Less than 20% of patients in Japan interested in new Alzheimer¡¯s drugs received one
Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.
51³Ô¹ÏÍø
/
Science & Health
Mar 25, 2026
Research team confirms safety of Alzheimer¡¯s drug Lecanemab
The research team examined data on the health status of 2,672 patients 28 weeks after the start of the treatment.
51³Ô¹ÏÍø
/
Science & Health
/
FOCUS
Sep 17, 2025
Japan¡¯s front-line researchers see bright path ahead for dementia treatment
Four scientists at the forefront of dementia research speak about what kind of future they envision for people with the condition.
51³Ô¹ÏÍø
/
Science & Health
Aug 7, 2025
Japan approves price cut for Alzheimer¡¯s drug Lecanemab
The drug¡¯s price will be lowered to ?97,277 for a 500-milligram bottle starting on Nov. 1.
51³Ô¹ÏÍø
/
Science & Health
Jul 10, 2025
Japan to cut price of Alzheimer¡¯s drug lecanemab
The health ministry is expected to cut the official price of the drug by up to 15% from the current level of about ?3 million per patient a year.
51³Ô¹ÏÍø
/
Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer¡¯s drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
WORLD
/
Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer¡¯s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
51³Ô¹ÏÍø
/
Science & Health
Sep 25, 2023
As Japan OKs Alzheimer¡¯s drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
51³Ô¹ÏÍø
/
Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer¡¯s drug lecanemab
The panel¡¯s endorsement will be followed by official approval by the health minister in coming days.
WORLD
/
Science & Health
/
ANALYSIS
Sep 30, 2022
Eisai drug¡¯s trial success raises hope for Alzheimer¡¯s prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
WHAT¡¯S TRENDING
Editors' Picks
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
Indian brothers make manga debut in Japan
Japan weighs regulating Pokemon cards amid trading mania
Low-income families in Japan cut food and air conditioning during summer break
Iran strikes on CIA facilities prompt questions about possible Russian role
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
The 180-day locals: Life on Japan¡¯s digital nomad visa
Japan reveals hint of new defense spending target in fiscal blueprint
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER